Local progression after radiofrequency ablation for pulmonary metastases

Cancer

Volumn 117, Issue 16, 2011, Pages 3781-3787

  Von Meyenfeldt, Erik M ^a   Prevoo, Warner ^a   Peyrot, David ^a   Fat, Nathalie Lai A ^a   Burgers, Sjaak J A ^a   Wouters, Michel W ^a   Klomp, Houke M ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

local ablation techniques; local progression; lung; metastasis; oligometastatic disease; progression free survival; radiofrequency ablation; survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER GROWTH; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS INHIBITION; OVERALL SURVIVAL; PNEUMOTHORAX; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENT CANCER; SURVIVAL RATE; SURVIVAL TIME; THORAX DRAINAGE; TREATMENT DURATION;

ADULT; AGED; CATHETER ABLATION; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL;

EID: 80051485753     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25958     Document Type: Article

References (24)

1. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg. 1997; 113: 37-49.
2. Martini N, McCormack PM., Evolution of the surgical management of pulmonary metastases. Chest Surg Clin N Am. 1998; 8: 13-27. (Pubitemid 28100953)
3. Pfannschmidt J, Dienemann H, Hoffmann H., Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg. 2007; 84: 324-338. (Pubitemid 46921128)
4. Pastorino U, Grunewald D., Surgical resection of pulmonary metastases. In:, Patterson GA, Cooper JD, Deslauriers J, eds. Pearson's Thoracic & Esophageal Surgery. Philadelphia, PA: Churchill Livingstone Elsevier; 2008: 851-854.
5. Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol. 2008; 9: 621-628.
6. Nakamura T, Matsumine A, Yamakado K, et al. Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas [corrected]. Cancer. 2009; 115: 3774-3781.
7. Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology. 2007; 243: 268-275. (Pubitemid 46579719)
8. Soga N, Yamakado K, Gohara H, et al. Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma. BJU Int. 2009; 104: 790-794.
9. Yamakado K, Hase S, Matsuoka T, et al. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol. 2007; 18: 393-398. (Pubitemid 46616705)
10. Yamakado K, Inoue Y, Takao M, et al. Long-term results of radiofrequency ablation in colorectal lung metastases: single center experience. Oncol Rep. 2009; 22: 885-891.
11. de Baere T, Palussiere J, Auperin A, et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology. 2006; 240: 587-596. (Pubitemid 44098659)
12. Gillams AR, Lees WR., Radiofrequency ablation of lung metastases: factors influencing success. Eur Radiol. 2008; 18: 672-677.
13. Clasen S, Krober SM, Kosan B, et al. Pathomorphologic evaluation of pulmonary radiofrequency ablation: proof of cell death is characterized by DNA fragmentation and apoptotic bodies. Cancer. 2008; 113: 3121-3129.
14. Rubin P, Brasacchio R, Katz A., Solitary metastases: illusion versus reality. Semin Radiat Oncol. 2006; 16: 120-130.
15. Jaklitsch MT, Mery CM, Lukanich JM, et al. Sequential thoracic metastasectomy prolongs survival by re-establishing local control within the chest. J Thorac Cardiovasc Surg. 2001; 121: 657-667.
16. Kim AW, Faber LP, Warren WH, et al. Repeat pulmonary resection for metachronous colorectal carcinoma is beneficial. Surgery. 2008; 144: 712-717; discussion 717-718.
17. Park JS, Kim HK, Choi YS, et al. Outcomes after repeated resection for recurrent pulmonary metastases from colorectal cancer. Ann Oncol. 2010; 21: 1285-1289.
18. Welter S, Jacobs J, Krbek T, et al. Long-term survival after repeated resection of pulmonary metastases from colorectal cancer. Ann Thorac Surg. 2007; 84: 203-210. (Pubitemid 46921140)
19. Treasure T., Pulmonary metastasectomy: a common practice based on weak evidence. Ann R Coll Surg Engl. 2007; 89: 744-748. (Pubitemid 350193680)
20. Yamagami T, Kato T, Hirota T, et al. Risk factors for occurrence of local tumor progression after percutaneous radiofrequency ablation for lung neoplasms. Diagn Interv Radiol. 2007; 13: 199-203. (Pubitemid 351395352)
21. Siva S, MacManus M, Ball D., Stereotactic radiotherapy for pulmonary oligometases. A systematic review. J Thorac Oncol. 2010; 5: 1091-1099.
22. Nguyen CL, Scott WJ, Young NA, et al. Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study. Chest. 2005; 128: 3507-3511. (Pubitemid 41698685)
23. Chua TC, Thornbury K, Saxena A, et al. Radiofrequency ablation as an adjunct to systemic chemotherapy for colorectal pulmonary metastases. Cancer. 2010; 116: 2106-2114.
24. Dupuy DE,. Microwave ablation compared with radiofrequency ablation in lung tissue-is microwave not just for popcorn anymore? Radiology. 2009; 251: 617-618.